{
  "cik": 1831828,
  "cik_padded": "0001831828",
  "entityName": "Vera Therapeutics, Inc.",
  "fiscal_years": [
    {
      "accn": "0001193125-26-077442",
      "filed": "2026-02-26",
      "fiscal_year": 2025,
      "form": "10-K",
      "fundamental_units": {
        "buybacks": "USD",
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "buybacks": 0.0,
        "capex": 630000.0,
        "cash": 354725000.0,
        "eps_diluted": -4.66,
        "free_cash_flow": -241734000.0,
        "net_income": -299615000.0,
        "operating_cash_flow": -241104000.0,
        "operating_income": -315473000.0,
        "stockholders_equity": 604521000.0,
        "total_assets": 734733000.0,
        "total_liabilities": 130212000.0
      },
      "period_end": "2025-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.21539698372761243,
        "roa_avg2y": -0.43097235787326654,
        "roa_period_end": -0.40778759086634186,
        "roe_avg2y": -0.5071017774753824,
        "roe_period_end": -0.49562380794050165
      }
    },
    {
      "accn": "0001193125-26-077442",
      "filed": "2026-02-26",
      "fiscal_year": 2024,
      "form": "10-K",
      "fundamental_units": {
        "buybacks": "USD",
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "buybacks": 13000.0,
        "capex": 972000.0,
        "cash": 92646000.0,
        "eps_diluted": -2.75,
        "free_cash_flow": -135651000.0,
        "net_income": -152148000.0,
        "operating_cash_flow": -134679000.0,
        "operating_income": -167170000.0,
        "stockholders_equity": 577155000.0,
        "total_assets": 655681000.0,
        "total_liabilities": 78526000.0
      },
      "period_end": "2024-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.13605703840389496,
        "roa_avg2y": -0.36608050508465195,
        "roa_period_end": -0.23204576615762845,
        "roe_avg2y": -0.44825879441400035,
        "roe_period_end": -0.26361722587519815
      }
    },
    {
      "accn": "0001193125-26-077442",
      "filed": "2026-02-26",
      "fiscal_year": 2023,
      "form": "10-K",
      "fundamental_units": {
        "buybacks": "USD",
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "buybacks": 0.0,
        "capex": 63000.0,
        "cash": 45681000.0,
        "eps_diluted": -2.25,
        "free_cash_flow": -92244000.0,
        "net_income": -95990000.0,
        "operating_cash_flow": -92181000.0,
        "operating_income": -102012000.0,
        "stockholders_equity": 101685000.0,
        "total_assets": 175546000.0,
        "total_liabilities": 73861000.0
      },
      "period_end": "2023-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.7263706544721443,
        "roa_avg2y": -0.6253807238884491,
        "roa_period_end": -0.5468082439930275,
        "roe_avg2y": -1.0749581450560772,
        "roe_period_end": -0.9439937060530067
      }
    },
    {
      "accn": "0001193125-26-077442",
      "filed": "2026-02-26",
      "fiscal_year": 2022,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 62000.0,
        "cash": 43459000.0,
        "eps_diluted": -3.35,
        "free_cash_flow": -67658000.0,
        "net_income": -89056000.0,
        "operating_cash_flow": -67596000.0,
        "operating_income": -90903000.0,
        "stockholders_equity": 76908000.0,
        "total_assets": 131435000.0,
        "total_liabilities": 54527000.0
      },
      "period_end": "2022-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.7089899620325584,
        "roa_avg2y": -0.8277233796350083,
        "roa_period_end": -0.6775668581428083,
        "roe_avg2y": -1.2157815699658703,
        "roe_period_end": -1.1579549591719978
      }
    },
    {
      "accn": "0000950170-24-036729",
      "filed": "2024-03-27",
      "fiscal_year": 2021,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 0.0,
        "cash": 79674000.0,
        "eps_diluted": -2.43,
        "free_cash_flow": -23708000.0,
        "net_income": -32609000.0,
        "operating_cash_flow": -23708000.0,
        "operating_income": -34402000.0,
        "stockholders_equity": 69592000.0,
        "total_assets": 83748000.0,
        "total_liabilities": 14156000.0
      },
      "period_end": "2021-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.20341418553856766,
        "roa_avg2y": -0.4715622333733424,
        "roa_period_end": -0.38937049242967,
        "roe_avg2y": 3.301174326786799,
        "roe_period_end": -0.46857397402000234
      }
    },
    {
      "accn": "0000950170-23-010288",
      "filed": "2023-03-28",
      "fiscal_year": 2020,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 99000.0,
        "cash": 53654000.0,
        "free_cash_flow": -34908000.0,
        "net_income": -53413000.0,
        "operating_cash_flow": -34809000.0,
        "operating_income": -52241000.0,
        "stockholders_equity": -89348000.0,
        "total_assets": 54554000.0,
        "total_liabilities": 4326000.0
      },
      "period_end": "2020-12-31",
      "ratio_units": {
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "roa_period_end": -0.9790849433588736,
        "roe_avg2y": 0.8485257672999936
      }
    },
    {
      "accn": "0000950170-22-004701",
      "filed": "2022-03-28",
      "fiscal_year": 2019,
      "form": "10-K",
      "fundamental_units": {
        "stockholders_equity": "USD"
      },
      "fundamentals": {
        "stockholders_equity": -36548000.0
      },
      "period_end": "2019-12-31",
      "ratios": {}
    }
  ],
  "latest_filing": {
    "accn": "0001193125-26-077442",
    "filed": "2026-02-26",
    "form": "10-K"
  },
  "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.",
  "schema_version": "1",
  "sic": "2834",
  "sic_description": "Pharmaceutical Preparations",
  "source_urls": {
    "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001831828.json",
    "sec_submissions": "https://data.sec.gov/submissions/CIK0001831828.json"
  },
  "ticker": "VERA"
}